13.07.2015 Views

DRUG REGISTRATION GUIDANCE DOCUMENT (DRGD) - BPFK

DRUG REGISTRATION GUIDANCE DOCUMENT (DRGD) - BPFK

DRUG REGISTRATION GUIDANCE DOCUMENT (DRGD) - BPFK

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Appearance/organoleptic(odor, color, taste)AssayHardness/friabilityDisintegration ordissolution rateMoisturecontentViscositypHMicrobial contentGranules/ ParticleSize variationRe-suspendabilityDrug Registration Guidance Document (<strong>DRGD</strong>)Testing Parameters of Stability Study for each type of dosage forms are shown inTable 12 below:Testing ParametersDosageFormOral powder √ √ √ √Hard capsule √ √ √ √ √Soft capsule √ √ √ √Coated and UncoatedTablet√√√(uncoated)√ √ √Coated and UncoatedPill/ Pellet√ √ √ √ √Suspension √ √ √ √ √ √ √Solution √ √ √ √ √Emulsion √ √ √ √ √Granules √ √ √ √ √*Notes:1. The list of tests for each product is not intended to be exhaustive, nor is it expected thatevery listed test to be included in the design of the stability study protocol for a particularfinished product.* Assay to determine the stability of a single active ingredient or a single marker/surrogateindicator that is susceptible to change during storage and is likely to influence quality shallbe sufficient to infer the overall stability of the TM/HS product irrespective of whether thefinished product contains single or multiple active ingredients.2. Justification must be given if one of the tests is not conducted for relevant dosage form.National Pharmaceutical Control Bureau (NPCB)First Edition, January 2013 Page | 196

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!